Identification Of Low Molecular Weight Metabolites That Can Predict Low Dose Aspirin Induced Gastric Toxicity And Resistance In Rats And Stable Coronary Artery Disease Patients Using Nmr-Based Pharmacometabonomics
Low Dose Aspirin (LDA) is the cornerstone of secondary prevention in coronary artery disease (CAD). Despite its established efficacy, it suffers a major setback of causing gastrointestinal toxicity. In addition, some patients still experience atherothrombotic events while on aspirin secondary prophy...
Saved in:
Main Author: | Abubakar, Sha’aban |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | http://eprints.usm.my/46590/1/Abubakar_20062019_24.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pilot study on platelet response to
aspirin with whole blood platelet aggregation methods in stable coronary artery disease patients
by: Sanada, Abu Bakar
Published: (2008) -
The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016) -
The role of MDCT coronary angiography in patients with low and intermediate risk of coronary artery disease /
by: Nur Adura Yaakup
Published: (2008) -
A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
by: Ibrahim, Bujang
Published: (2021) -
Predicting Gentamicin Induced Nephrotoxicity Using
Pharmacometabonomic Approach
by: Aziz, Fatimatuzzahra’ Abd.
Published: (2019)